13F-HR filed by AIGH Capital Management LLC
AIGH Capital Management LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-02, with 34 holding rows worth $413,146,708.
- Accession
- 0001214659-26-001042
- Filer
- CIK 1835943
- Filed
- 2026-02-02
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 68 entries on the cover page, a total value of $413,146,708 stated on the cover page (in dollars after the unit check, H1), rows summing to $413,146,708 with VALUE read as dollars as filed, 13F file number 028-20823. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerWorth Venture Partners, LLC028-17947
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SanDisk Corporation | 80004C200 | COM | 280,000 | $66,466,400 | dollars as filed | |
| ZOOM COMMUNICATIONS INC | 98980L901 | CALL | 700,000 | $60,403,000 | dollars as filed | call |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 624,719 | $24,301,569 | dollars as filed | |
| PERSONALIS INC | 71535D106 | COMMON STOCK | 2,900,000 | $23,084,000 | dollars as filed | |
| NLIGHT INC | 65487K100 | COM | 600,103 | $22,509,863 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 1,992,021 | $18,565,635 | dollars as filed | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 1,998,431 | $17,626,162 | dollars as filed | |
| BK TECHNOLOGIES CORP | 05587G203 | COMMON STOCK | 211,453 | $15,772,279 | dollars as filed | |
| DOMO INC | 257554105 | COM CL B | 1,837,762 | $15,492,333 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 4,000,000 | $14,800,000 | dollars as filed | |
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 1,500,000 | $14,100,000 | dollars as filed | |
| FENNEC PHARMACEUTICALS INC | 31447P100 | COMMON STOCK | 1,581,501 | $12,177,558 | dollars as filed | |
| LIGHTPATH TECHNOLOGIES INC | 532257805 | COM CL A | 1,030,738 | $11,131,970 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 2,000,000 | $10,540,000 | dollars as filed | |
| ZEVRA THERAPEUTICS INC | 488445906 | COM NEW | 1,000,000 | $8,960,000 | dollars as filed | call |
| INTELLICHECK MOBILISA INC | 45817G201 | COM NEW | 1,213,434 | $8,105,739 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 2,000,000 | $7,620,000 | dollars as filed | |
| ARQ INC | 00770C101 | COM | 2,273,092 | $7,433,010 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 1,150,000 | $6,704,500 | dollars as filed | |
| BYRNA TECHNOLOGIES INC | 12448X201 | COM NEW | 394,906 | $6,630,472 | dollars as filed | |
| POLYPID LTD | M8001Q126 | COM | 1,342,972 | $5,828,498 | dollars as filed | |
| COYA THERAPEUTICS INC | 22407B108 | CMN | 975,404 | $5,657,343 | dollars as filed | |
| SEAGATE TECHNOLOGY HLDNGS PL | G7997R903 | CALL | 20,000 | $5,507,800 | dollars as filed | call |
| TALPHERA INC | 00444T209 | COM NEW | 4,661,502 | $5,314,112 | dollars as filed | |
| APYX MEDICAL CORPORATION | 03837C106 | COM | 1,104,970 | $3,867,395 | dollars as filed | |
| RENOVORX INC | 75989R107 | COM NEW | 2,833,894 | $3,671,068 | dollars as filed | |
| GRACE THERAPEUTICS INC | 00439U104 | COM | 907,217 | $3,146,077 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 3,068,185 | $2,125,332 | dollars as filed | |
| NEURAXIS INC | 64134X201 | COM | 400,000 | $1,816,000 | dollars as filed | |
| IDEAL PWR INC | 451622203 | COM NEW | 491,989 | $1,520,246 | dollars as filed | |
| SMARTKEM INC | 83193D203 | COM NEW | 675,000 | $718,875 | dollars as filed | |
| QUOIN PHARMACEUTICALS LTD | 74907L409 | SPONSORED ADS | 49,323 | $711,731 | dollars as filed | |
| BIOFRONTERA INC | 09077D209 | COM NEW | 915,210 | $521,670 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 370,541 | $316,071 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-26-001042 | this filing | 2026-02-02 | acceptance time not in the bulk data set |